Vivos Therapeutics IncNASDAQ:VVOS
- LAST PRICE3.3800
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots3.3500/ 1
- Ask / Lots3.4500/ 1
- Open / Previous Close--- / 3.3800
- Day Range---
- 52 Week Range
- Volume770
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | VVOS |
|---|---|---|
| 09:32 ET | 723 | 3.25 |
| 09:33 ET | 1250 | 3.26 |
| 09:37 ET | 605 | 3.23 |
| 09:44 ET | 250 | 3.2265 |
| 09:46 ET | 745 | 3.22 |
| 09:48 ET | 2800 | 3.2 |
| 09:50 ET | 100 | 3.15 |
| 09:51 ET | 1000 | 3.16 |
| 09:55 ET | 4750 | 3.103 |
| 09:57 ET | 1550 | 3.11 |
| 10:00 ET | 600 | 3.12 |
| 10:02 ET | 2084 | 3.15 |
| 10:04 ET | 4000 | 3.15 |
| 10:08 ET | 2900 | 3.15 |
| 10:09 ET | 250 | 3.1236 |
| 10:11 ET | 150 | 3.15 |
| 10:13 ET | 2160 | 3.15 |
| 10:18 ET | 150 | 3.18 |
| 10:20 ET | 200 | 3.175 |
| 10:22 ET | 200 | 3.17 |
| 10:24 ET | 7300 | 3.14 |
| 10:26 ET | 6100 | 3.1999 |
| 10:27 ET | 1500 | 3.2101 |
| 10:29 ET | 14550 | 3.24 |
| 10:36 ET | 3800 | 3.24 |
| 10:38 ET | 7858 | 3.29 |
| 10:40 ET | 1000 | 3.2573 |
| 10:42 ET | 100 | 3.26 |
| 10:45 ET | 1146 | 3.29 |
| 10:54 ET | 500 | 3.2701 |
| 10:56 ET | 912 | 3.28 |
| 11:00 ET | 2400 | 3.2701 |
| 11:02 ET | 3612 | 3.26 |
| 11:09 ET | 100 | 3.24 |
| 11:14 ET | 3500 | 3.2 |
| 11:16 ET | 161 | 3.21 |
| 11:20 ET | 9670 | 3.28 |
| 11:21 ET | 4000 | 3.2702 |
| 11:23 ET | 400 | 3.26 |
| 11:27 ET | 300 | 3.2505 |
| 11:30 ET | 100 | 3.245 |
| 11:39 ET | 1600 | 3.2285 |
| 11:48 ET | 1100 | 3.21 |
| 11:54 ET | 2443 | 3.25 |
| 11:56 ET | 676 | 3.27 |
| 11:59 ET | 416 | 3.2699 |
| 12:03 ET | 3715 | 3.245 |
| 12:06 ET | 300 | 3.27 |
| 12:10 ET | 100 | 3.26 |
| 12:14 ET | 6300 | 3.28 |
| 12:15 ET | 400 | 3.2889 |
| 12:21 ET | 100 | 3.245 |
| 12:24 ET | 300 | 3.2205 |
| 12:28 ET | 200 | 3.23 |
| 12:32 ET | 4300 | 3.215 |
| 12:33 ET | 2000 | 3.1904 |
| 12:37 ET | 153 | 3.23 |
| 12:39 ET | 100 | 3.23 |
| 12:46 ET | 3890 | 3.26 |
| 12:48 ET | 3468 | 3.16 |
| 12:50 ET | 316 | 3.17 |
| 12:51 ET | 2070 | 3.22 |
| 12:57 ET | 1030 | 3.22 |
| 01:11 ET | 2600 | 3.205 |
| 01:22 ET | 100 | 3.22 |
| 01:26 ET | 1000 | 3.205 |
| 01:36 ET | 100 | 3.19 |
| 01:38 ET | 4385 | 3.21 |
| 01:42 ET | 2000 | 3.1995 |
| 01:47 ET | 100 | 3.19 |
| 01:49 ET | 113 | 3.19 |
| 01:56 ET | 800 | 3.2 |
| 02:07 ET | 6598 | 3.18 |
| 02:12 ET | 3599 | 3.210751 |
| 02:16 ET | 2946 | 3.22 |
| 02:18 ET | 3804 | 3.2 |
| 02:23 ET | 250 | 3.195 |
| 02:25 ET | 985 | 3.2 |
| 02:32 ET | 625 | 3.1888 |
| 02:38 ET | 375 | 3.1891 |
| 02:39 ET | 600 | 3.18 |
| 02:41 ET | 433 | 3.18 |
| 02:54 ET | 250 | 3.1794 |
| 02:57 ET | 950 | 3.18 |
| 02:59 ET | 12140 | 3.19 |
| 03:03 ET | 300 | 3.21 |
| 03:06 ET | 100 | 3.2 |
| 03:14 ET | 1200 | 3.2 |
| 03:15 ET | 2200 | 3.22 |
| 03:17 ET | 880 | 3.21 |
| 03:19 ET | 100 | 3.2193 |
| 03:24 ET | 1020 | 3.1989 |
| 03:26 ET | 11400 | 3.2 |
| 03:28 ET | 500 | 3.19 |
| 03:30 ET | 1000 | 3.22 |
| 03:32 ET | 1000 | 3.2034 |
| 03:39 ET | 2228 | 3.225 |
| 03:42 ET | 852 | 3.23 |
| 03:44 ET | 7233 | 3.28 |
| 03:46 ET | 2221 | 3.28 |
| 03:48 ET | 2426 | 3.275 |
| 03:50 ET | 8150 | 3.34 |
| 03:51 ET | 4789 | 3.36 |
| 03:53 ET | 11325 | 3.39 |
| 03:55 ET | 2900 | 3.38 |
| 03:57 ET | 1823 | 3.3862 |
| 04:00 ET | 10744 | 3.38 |
Nov 20, 2024
DJ Vivos Therapeutics Price Target Maintained With a $6.60/Share by Ascendiant Capital, from 4:54AM ET on Wednesday Nov 20, 2024 by Dow Jones
4:54AM ET on Wednesday Nov 20, 2024 by Dow Jones
Nov 19, 2024
DJ Vivos Therapeutics Is Maintained at Buy by Alliance Global Partners, from 12:08PM ET on Tuesday Nov 19, 2024 by Dow Jones
12:08PM ET on Tuesday Nov 19, 2024 by Dow Jones
Nov 14, 2024
Vivos Therapeutics Reports Third Quarter 2024 Financial Results and Provides Operational Update, from 4:05PM ET on Thursday Nov 14, 2024 by Dow Jones
4:05PM ET on Thursday Nov 14, 2024 by Dow JonesPress Release: Vivos Therapeutics Reports Third Quarter 2024 Financial Results and Provides Operational Update, from 4:05PM ET on Thursday Nov 14, 2024 by Dow Jones
4:05PM ET on Thursday Nov 14, 2024 by Dow Jones
Nov 13, 2024
Vivos Therapeutics Schedules Release of Third Quarter 2024 Financial Results and Conference Call, from 5:00PM ET on Wednesday Nov 13, 2024 by Dow Jones
5:00PM ET on Wednesday Nov 13, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Vivos Therapeutics Inc | 15.2M | -0.6x | --- |
Lifeward Ltd | 16.8M | -0.9x | --- |
Applied DNA Sciences Inc | 7.8M | 0.0x | --- |
Scientific Industries Inc | 7.9M | -1.4x | --- |
Innovative Eyewear Inc | 16.0M | -0.7x | --- |
Dror Ortho-Design Inc | 14.4M | -1.2x | --- |
Company Information
Vivos Therapeutics, Inc. is a medical technology company focused on developing and commercializing diagnostic and treatment methods for patients suffering from breathing and sleep issues arising from certain dentofacial abnormalities such as obstructive sleep apnea (OSA) and snoring in adults. The Company calls its solution The Vivos Method. The Vivos Method represents the first clinically effective nonsurgical, noninvasive and nonpharmaceutical solution for treating mild to severe OSA. The Vivos Method includes treatment regimens that employ the proprietary Complete Airway Repositioning and/or Expansion (CARE) appliance therapy and other modalities that alter the size, shape and position of the soft tissues that comprise a patient's upper airway and/or palate. The Vivos Method comprises various products and services, including Vivos CARE oral appliance therapy, Vivos oral appliances and therapies outside of CARE system, Vivos AireO2, and Vivos Airway Intelligence Service.
Contact Information
- Headquarters
- 7921 Southpark Plaza,, Suite 210LITTLETON, CO, United States 80120
- Phone
- ---
- Fax
- 302-655-5049
Executives
- Chairman of the Board, Chief Executive Officer, Co-Founder
- R. Kirk Huntsman
- Chief Financial Officer
- Bradford Amman
- Independent Director
- Ralph Green
- Independent Director
- Anja Krammer
- Independent Director
- Mark Lindsay
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $15.2M |
|---|---|
Revenue (TTM) | $14.6M |
Shares Outstanding | 4.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 7.66 |
EPS | $-5.62 |
Book Value | $0.22 |
P/E Ratio | -0.6x |
Price/Sales (TTM) | 1.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -85.72% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
